Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "DNA in rapidly dividing tumor cells" refers to the genomic material within cancerous cells that are undergoing frequent division. Unlike specific molecular targets such as proteins or receptors, this designation describes a cellular component—namely the double-stranded deoxyribonucleic acid—that serves as both a blueprint for cellular function and a target for many anticancer therapies. Rapidly proliferating tumor cells rely on continuous and accurate replication of their genomic DNA; however, this process is often dysregulated due to mutations affecting cell cycle checkpoints and repair mechanisms. Many chemotherapeutic drugs exploit this vulnerability by inducing irreparable damage during replication or by interfering with enzymes essential for copying genetic material. While targeting "tumor cell DNA" can be effective against malignancies characterized by high proliferation rates, it also poses significant risks due to collateral effects on healthy tissues with high turnover rates. Note on correctness: This entry does not correspond to a single defined molecular target like an enzyme or receptor but rather describes a class of molecules present in all nucleated human cells. As such, while "DNA in rapidly dividing tumor cells" is indeed targeted therapeutically—primarily through cytotoxic chemotherapy—it lacks specificity compared with canonical drug targets. This makes it an imprecise entry from the perspective of structured pharmacological databases. “A number of drugs under investigation inhibit the remaining functional checkpoints in these [cancer] cells... The ultimate result is programmed cell death... These results point to RepID expression levels as a way to gauge cancer cells’ sensitivity to replication inhibitors.” “The gene set enrichment analysis... indicated that the cell cycle played a crucial role in colon cancer.... The proliferation of cancer cells is not under control.... This indicates that cancer cells proliferate due to dysregulation... regulated by the cell cycle.”
Induction of DNA damage leading to apoptosis in rapidly dividing cells; Inhibition of DNA replication enzymes or processes
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA in rapidly dividing tumor cells.